AlphaCore Capital’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

AlphaCore Capital’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$20.1K	Buy	+74	New	+$19.2K	﹤0.01%	1587

Other funds holding FBT

LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return

Nilsine Partners Greenwood Village, Colorado $1.44B AUM 38.08% 1-Year Est. Return

D.A. Davidson & Co Great Falls, Montana $18.6B AUM 17.65% 1-Year Est. Return

Bensler Bellevue, Washington $1.06B AUM 29.38% 1-Year Est. Return

Csenge Advisory Group Clearwater, Florida $2.53B AUM 18.15% 1-Year Est. Return

NewSquare Capital Newtown Square, Pennsylvania $1.38B AUM 24% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $45.2B AUM 20.72% 1-Year Est. Return

Kestra Advisory Services Austin, Texas $35.1B AUM 20.13% 1-Year Est. Return

AlphaCore Capital's FBT Position: Q3 2026 in Review

AlphaCore Capital opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q3 2026: 74 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #1587 among its holdings.

203 funds tracked by Wall St. Rank hold FBT as of Q3 2026.

AlphaCore Capital held 74 shares of First Trust NYSE Arca Biotechnology Index Fund worth $20.1K as of Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund was a new AlphaCore Capital position in Q3 2026.
First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of AlphaCore Capital's portfolio in Q3 2026, its #1587 holding.
203 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q3 2026.

Based on AlphaCore Capital's 13F filing for Q3 2026, filed 4 Nov 2026.